Last edition
News about "iOnctura"
iOnctura Secures EUR 80 Million in Series B Financing Round
iOnctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, has closed a EUR 80 million Series B financing.
IOnctura | 21/06/2024 | By Aishwarya | 208
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members